S. Farrow et al., METOCLOPRAMIDE DOES NOT INHIBIT ATRIAL NATRIURETIC FACTOR-STIMULATED DIURESIS IN MAN, Aviation, space, and environmental medicine, 67(3), 1996, pp. 248-252
Background: An understanding of the reflex hormonal responses that occ
ur with a redistribution of the blood volume upon exposure to microgra
vity or during water immersion is operationally relevant. Further, dop
amine receptor antagonists, which are used in the treatment of the mot
ion sickness induced by microgravity, or at sea, may affect fluid meta
bolism. Atrial natriuretic factor (ANF) is a potent diuretic and natri
uretic hormone that is released following central blood volume expansi
on in man. ANF is also a potent inhibitor of angiotensin- and potassiu
m-stimulated aldosterone release. Hypothesis: Since ANF-induced diures
is may be mediated by dopamine, we sought to determine whether inhibit
ion of dopamine receptors blocks ANF-induced natriuresis and diuresis.
Also, since ANF has been shown to inhibit aldosterone secretion induc
ed by adrenocorticotropic hormone (ACTH) in vitro, we investigated whe
ther ANF decreases aldosterone in man infused with exogenous ACTH. Met
hods and Results: In six healthy, sodium-replete men, infusion of synt
hetic ANF (0.01 mu g . kg . min, Anaritide, Wyeth Laboratories) signif
icantly increased urine flow from 7.1 +/- 0.7 to 11.7 +/- 1.8 ml . min
(-1) (p < 0.05) and decreased aldosterone from 74.7 +/- 9.0 to 55.8 +/
- 6.5 pg . ml(-1) (p = N.S.). Metoclopramide (Met), a dopaminergic ant
agonist, increased plasma aldosterone from 104.5 +/- 8.9 to 163 +/- 12
.5 pg . ml(-1) (p < 0.05). ANF-induced diuresis was not inhibited by M
et, but ANF significantly inhibited Met-stimulated increases in plasma
aldosterone. ANF did not attenuate ACTH-stimulated increases in plasm
a aldosterone. Also, ANF-induced diuresis and natriuresis were not aff
ected by concomitant infusions of ACTH, but the ANF-induced kaliuresis
was significantly attenuated by ACTH. Conclusion: These studies sugge
st: a) Synthetic ANF induces a diuresis, natriuresis and kaliuresis; b
) the D-2 receptor antagonist Met increases plasma aldosterone; c) ANF
-induced diuresis is not subject to dopaminergic blockade with Met, bu
t Met-induced increases in plasma aldosterone are inhibited by ANF; an
d d) ANF does not attenuate ACTH-stimulated increases in mineralocorti
coid production. These studies have operational significance, as they
demonstrate that D-2 dopaminergic blockade by the antinausea agent met
oclopramide does not prevent the effects of increased ANF in response
to central volume expansion such as occurs during exposure to microgra
vity or following water immersion.